Showing results (91-100 of 267) with videos related to
Sort By:
Pageof 27
Frontiers in Immunology|November 10, 2017
Decreased Immunity to Varicella Zoster Virus in Giant Cell ArteritisChristien Rondaan, Kornelis S M van der Geest, Elisabeth Eelsing, et al.The Lancet. Rheumatology|April 4, 2024
Large vessel giant cell arteritisKornelis S M van der Geest, Maria Sandovici, Thorsten A Bley, et al.Journal of Autoimmunity|July 8, 2021
Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumaticaJacoba C Graver, Wayel Abdulahad, Kornelis S M van der Geest, et al.Frontiers in Immunology|March 10, 2018
Checks and Balances in Autoimmune VasculitisRebeca Hid Cadena, Wayel H Abdulahad, G A P Hospers, et al.International Journal of Environmental Research and Public Health|April 3, 2021
Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis PatientsMenke J de Smit, Johanna Westra, Marcel D Posthumus, et al.Clinical and Experimental Rheumatology|March 24, 2015
Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practiceSuzanne Arends, Eveline van der Veer, Fleur B S Kamps, et al.Plos One|April 25, 2018
Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitorsMarlies J G Carbo, Anneke Spoorenberg, Fiona Maas, et al.Cancer Immunology, Immunotherapy : CII|March 17, 2018
Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanomaRob R H van den Brom, Kornelis S M van der Geest, Elisabeth Brouwer, et al.Rheumatology (Oxford, England)|July 12, 2019
High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumaticaYannick van Sleen, Annemieke M H Boots, Wayel H Abdulahad, et al.Clinical and Experimental Rheumatology|February 18, 2016
Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-α blocking therapyFiona Maas, Anneke Spoorenberg, Elisabeth Brouwer, et al.Pageof 27